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The pathophysiology of osteoporotic hip fracture
David Metcalfe*
ABSTRACT: Osteoporotic hip fractures have a profound impact on the physical health and
psychosocial wellbeing of patients. In addition, osteoporosis has considerable economic implications
and is projected to become an increasing burden on developed economies over the coming decades.
Nevertheless, the risk factors for both osteoporosis and hip fracture are both well understood and
preventable, often with only minor lifestyle changes. This narrative review explores the pathological
process underlying osteoporosis and considers how each of the major risk factors contributes to the
pathology of this disease. It is hoped that a greater understanding of individual risk factors will result
in renewed efforts to promote increased bone density before patients present with hip fracture.
INTRODUCTION
Osteoporosis is a generalised skeletal disorder
characterised by low bone mass and micro-architectural
deterioration of bone which leads to fragility and risk of
fracture (1). The World Health Organisation (WHO)
criteria for osteoporosis are met when bone mineral
density (BMD) falls 2.5 standard deviations below the
mean found in young adult women (2). Reduced BMD
may be caused by a range of factors such as endocrine
disturbances, dietary deficiencies, or side effects of
pharmacological interventions (3). One consequence of
osteoporosis is hip fracture which may also be
attributed to extra-skeletal factors such as frailty, failing
eyesight, and a tendency to fall (4). The risk factors
associated with reduced BMD are described in Table 1.
Although osteoporosis commonly affects the hip and
lumbar vertebrae, it may also be found at other sites
such as the radius, tibia and ribs (5). One consequence
of reduced BMD is that osteoporosis is strongly
associated with low trauma fracture. Indeed, up to 51%
of fractures in women and 24% of those in men are
attributable to osteoporosis (6). In the USA, as many as
1.5 million osteoporotic fractures are recorded annually,
including 250,000 hip fractures (7). As a consequence,
estimates of the economic burden of osteoporosis in the
USAhave climbed as high as $17 billion per annum (8).
Furthermore, in Switzerland, osteoporosis accounts for
more hospital bed occupancy than myocardial
infarction, stroke or breast cancer (9).
In addition to the economic consequences, hip
fracture in particular is associated with profound
disability and psychosocial sequelae. For example, 50%
of hip fracture patients lose the ability to walk without
assistance and 25% require domiciliary care thereafter.
Furthermore, the mortality rate over the 6 months
following hip fracture may be as high as 30% (10).
The causes of osteoporosis and hip fracture are,
however, well characterised and offer multiple
opportunities both for prevention and disease
management. This narrative review considers the
pathophysiology of osteoporosis with particular
reference to fragility fractures of the hip.
ANATOMY OF THE HIP
The hip is a multiaxial ball-and-socket synovial joint
in which the rounded head of the femur articulates with
the concave acetabulum of the pelvis. A
fibrocartilaginous lip known as the acetabular labrum
increases the depth of the acetabulum and grips the
femur in position (11). Both joint faces are covered with
a dense lubricative layer of articular hyaline cartilage
except for the fovea which holds the intracapsular
ligament of the femoral head, or ligamentum teres
femoris (12). The primary function of this joint is to
sustain body weight in both static and dynamic
postures.
Although the hip joint is only surpassed in flexibility
by the glenohumeral (shoulder) joint, some range of
mobility has been sacrificed in favour of further
stability (13). This is probably because the weight of the
upper body is entirely supported by this joint on
standing (12). One consequence of this stability is that
the hip joint of a healthy patient should not fracture in
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the absence of high energy trauma. Indeed, the femoral
head is classically fractured only in high impact road
traffic accidents in which the dash board strikes the
knee to rupture the joint capsule (14).
However, the femoral head is supported by a
relatively thin structure known as the femoral neck
which is more prone to fracture than the joint itself is to
dislocation (13). The femoral neck is particularly
vulnerable in patients suffering from bone disorders
such as Paget’s disease, osteomalacia, osteopetrosis,
osteogenesis imperfecta and metabolic bone disease.
Femoral neck fractures are also frequently associated
with primary tumours of the bone, cancer metastases
and infection of the bone (15). However, the majority of
patients presenting with femoral neck fractures are
those with osteoporosis (16). Although osteoporosis
may be caused by multiple factors, all of these are
thought to act by subverting the normal physiology of
healthy bone.
PHYSIOLOGY OF BONE
Mammalian bones may be classified as long, short,
flat, irregular or sesamoid. The long bones, which
include the femurs, are a major component of the
human skeleton and fulfil a number of different
functions. As well as protecting soft tissues and
determining posture, long bones also provide a site for
haematopoiesis. Furthermore, they are important sites
of mineral storage, particularly of calcium and
phosphate (17). The multiple functions of bone require
a dynamic structure to cope with mineral storage and
adaptation to environmental stress. For these reasons,
osseous tissue is continually broken down and re-
deposited in a process known as ‘remodelling’.
Bone remodelling
In healthy adult bone, matrix exists in a dynamic
equilibrium of deposition by osteoblasts and resorption
by osteoclasts. The latter typically aggregate together
and eliminate bone over a period of ~3 weeks, leaving a
tunnel of between 0.2mm and 1mm. Osteoblasts then
act to deposit new matrix and these cells may be found
acting on 4% of the surface of adult human bone at any
time (18). New bone is deposited in concentric circles
known as lamellae and, in this way, up to 10% of bone
is re-deposited in the adult skeleton each year (19). The
purposes of continual bone remodelling are twofold:
1.Adjustment of bone shape and thickness in response
to environmental and musculoskeletal stresses.
2. Replenishment of old bone which is weaker than
newly deposited matrix (19).
AETIOLOGY OF OSTEOPOROSIS
A number of risk factors for reduced BMD exert their
effect through subversion of the remodelling process.
Indeed, osteoporosis may be seen simply as a failure of
bone deposition to match the rate of resorption (19).
Many of these risk factors were summarised earlier in
Table 1.Although a number affect patients in adulthood,
many other risk factors exert their influence during
adolescence or earlier in the lifespan when bone
deposition initially takes place (19).
Alcohol and tobacco consumption
Many studies have suggested an association between
excess alcohol consumption and fragility fractures. One
large cohort study has, for example, shown that heavy
alcohol consumption (>207ml per week) accompanies
an increased risk of fracture in men (RR=1.26) and
women (RR=1.54) (21). This relationship is not simply
a result of falls under the influence of alcohol as
histological changes have also been noted in the bone
structure of alcohol abusers (22). However, these may
be partially explained by confounding factors
associated with alcoholism such as liver damage,
hypogonadism and nutritional deficiencies.
Nevertheless, alcohol is known to increase parathyroid
hormone (PTH) and to reduce concentrations of vitamin
D metabolites required for efficient calcium absorption
(23). Furthermore, alcohol suppresses bone
mineralization by osteoblasts. The consequences of
Table 1: Risk factors predisposing to low BMD (20).
General factors Female sex
Caucasian or Asian ethnicity
Advanced age
Early menopause
Slender habitus
Lack of exercise
Smoking
Family history
Excess alcohol
Poor nutrition (low calcium or high protein)
Drug products Corticosteroids
Heparin
Cyclosporin
Cytotoxic drugs
Diseases
• Endocrine disease
• Joint disease
• Other diseases
Cushing’s syndrome
Hyperparathyroidism
Hypogonadism
Acromegaly
Type I diabetes mellitus
Rheumatoid arthritis
Chronic renal failure
Chronic liver disease
Mastocytosis
Anorexia nervosa
Inflammatory bowel disease
Coeliac diseaseOsteoporotic Hip Fracture 53 Vol. 11 No. 1
these effects are calcium excretion in the urine
(hypercalciuria), lowered serum calcium
(hypocalcaemia) and reduced BMD (23). Despite these
risks, a mounting body of evidence suggests that
moderate alcohol intake may increase BMD, possibly
by increasing oestrogen titres (22).
Individuals who smoke tobacco are at increased risk
of developing osteoporosis, even when alcohol is
eliminated as a confounding factor. Although the
precise mechanism is not understood, there remains a
clear dose-dependent relationship between smoking and
reduced BMD (24).
High salt diet
Additional dietary risk factors include high salt and
high protein diets.Although excessive salt consumption
(>9g/day) is not itself a cause of osteoporosis (25), it is
known to reduce BMD by increasing renal calcium
excretion (26). Indeed, every 100mmol of ingested
sodium is thought to deplete the body of around 1mmol
of calcium (27). Protein also increases the level of renal
calcium excretion. One longitudinal study has, for
example, found that high dietary protein causes
hypercalciuria and reduced BMD in the elderly (28).
Indeed, increasing dietary protein ingestion from 40g to
80g leads to the excretion of an additional 1mmol
calcium each day (27). Low protein diets have,
however, also been associated with fracture, although
this apparent relationship may be explained by
confounding factors such as malnutrition and slender
habitus (28).
Dietary deficiencies and anorexia nervosa
Poor nutrition is also strongly associated with reduced
BMD.According to one meta-analysis of 20 studies, the
increased calcium requirement and reduced absorption
at menopause may be negated by calcium
supplementation (27). Other nutritional factors also
affect calcium homeostasis. For example, vitamin D is
required for efficient absorption of calcium and one
meta-analysis has shown that calcium and vitamin D are
more effective than calcium alone in elevating BMD
(29). Vitamin D deficiencies, then, are associated with
calcium malabsorption, reduced BMD and increased
risk of hip fracture (27). As sunlight is a necessary
component of vitamin D synthesis, populations exposed
less frequently to the sun are at increased risk. Such
populations include women dressed according to
Shariah law and the homebound elderly. One study has
shown that 38% of nursing home residents in the USA
had serum levels of 25-hydroxyvitamin D (25-OHD)
below 25nM, compared with a normal range of 25-
137nM (30). Similarly, the prevalence of vitamin D
deficiency and high bone turnover in a cohort of
Muslim women living inAustralia was found to be 68%
and 38.6% respectively (31).
Vitamin K, obtained primarily from leafy green
vegetables, is another agent that protects bone matrix. It
fulfils this function primarily through facilitating the
carboxylation of glutamyl residues on bone proteins
such as osteocalcin. One prospective study of 72,237
women, for example, found that those with a low
vitamin K intake were significantly more likely to suffer
a low trauma hip fracture (32).
These dietary deficiencies, as well as hormonal
changes secondary to cachexia, are responsible for the
reduced BMD observed in patients with anorexia
nervosa. Nutritional rehabilitation can increase the
BMD of women with anorexia nervosa beyond that
achieved with administration of oestrogen alone (33).
Slender habitus is, however, an independent risk factor
for osteoporosis with both total fat mass and total lean
mass exerting a protective effect on bone in
postmenopausal women (34).
Glucocorticoid administration
Glucocorticoids are a class of steroid hormones that
bind the intracellular cortisol receptor. They are
primarily used for their anti-inflammatory properties in
respiratory, musculoskeletal and cutaneous diseases.
Indeed, around 0.9% of people on the United Kingdom
General Practice Research Database are prescribed
glucocorticoids at any one time (35). Glucocorticoids
are, however, associated with greatly reduced BMD.
They are the most frequent cause of secondary
osteoporosis and as many as 50% of patients receiving
long-term glucocorticoid therapy sustain a fragility
fracture(36). In particular, the relative risk of hip
fracture in patients receiving a daily glucocorticoid dose
of ≥30mg is 3.13 (95% CI = 1.49-6.59) (37).
These drugs exert their osteoporotic effects through a
number of mechanisms. For example, they impair the
replication and differentiation of osteoblasts, as well as
induce apoptosis in mature osteoblasts (36).
Glucocorticoids also downregulate genes encoding
matrix proteins such as collagen and osteocalcin(38).
Finally, glucocorticoids are associated with reduced
intestinal calcium absorption as a result of down-
regulating the gene encoding TRPV6, a Ca2+ channel
normally expressed in duodenal epithelium (39).
Although vitamin D supplementation given alongside
glucocorticoids can negate the damage to bone,
awareness of glucocorticoid-induced osteoporosis
remains low among primary and secondary care
physicians (40).
Female sex
Women account for over 80% of osteoporosisIntrinsic Factors Balance, gait or mobility problems
Medications
(e.g. sedatives, anti-hypertensive drugs)
Visual impairment
Impaired cognition
Postural hypotension
Alcohol
Environmental factors Poor lighting
Steep stairs
Carpets or rugs
Slippery floors
Badly fitting footwear
Inaccessible cupboards or windows
Table 2: Extra-skeletal risk factors for hip fracture (55, 56).
osteoclast lifespan, abnormal osteocyte signalling or a
physiological response to inactivity in old age (53). The
efficiency of calcium absorption in the duodenum is
also known to decline with age (19).
EXTRA-SKELETAL RISK FACTORS FOR HIP
FRACTURE
Although reduced BMD in osteoporosis elevates
fracture risk, fracture itself may also be attributed to
falling, often from standing height. Table 2 summarises
the most significant extra-skeletal risk factors which
may lead to falling and subsequent fracture. Falls
prevention services have now been implemented by a
number of countries and have had some success in
reducing the incidence of hip fractures among elderly
populations (54).
HEALTH PROMOTION
Health promotion strategies primarily aim to
eliminate modifiable risk factors. As osteoporosis
screening is not commonplace, these strategies are often
targeted at populations considered to be ‘at risk’.
Weight bearing exercise is, for example, recommended
for elderly community-dwelling people (57). Non-
pharmacological interventions include exercise, redress
of dietary deficiencies and falls prevention. These
health promotion strategies are also an extremely
important aspect of fragility fracture management.
Non-pharmacological interventions may be used both
as preventative measures and as management strategies
following hip fracture. Exercise and dietary intake are
important considerations throughout the lifespan as
skeletal strength in old age is largely determined by
mineral deposition in childhood and adolescence (19).
Exercise
A number of systematic reviews have concluded that
weight bearing exercise can increase BMD in both
healthy and osteoporotic women (58). In light of this
evidence, resistance and strength training are now
diagnoses (41). Female sex is a risk factor for low BMD
both because of the reduced size and cortical thickness
characteristic of female bones and the decline in
oestrogen titres at menopause (42). Oestrogen has a
protective effect on bone, primarily by blocking
osteoclast activity. It achieves this through the
inhibition of a number of cytokines, including IL-1 and
TNF, which otherwise activate mature osteoclasts (43).
The bone-sparing properties of oestrogen explain why
early menopause predisposes to low BMD and
underlies the rationale for using hormone replacement
therapy (HRT) to avert osteoporosis. Indeed,
postmenopausal oestrogen deficiency is the most
significant non-genetic factor in the aetiology of
osteoporosis (25).
Pregnancy has, however, also been associated with
osteoporosis, particularly with vertebral fragility
fractures in the third trimester (44). Nevertheless, long-
term studies of postpartum women using dual-energy
X-ray absorptiometry (DEXA) have found that reduced
BMD during pregnancy and lactation is usually only a
temporary phenomenon (45). Although cases of
osteoporotic hip fracture have been reported during
pregnancy(46), the extent of this relationship has yet to
be determined.
Although predominantly a disease of older women,
men do suffer from osteoporosis. In Croatia, as many as
5.8% of men over 50 qualify as osteoporotic on analysis
of the calcaneus using a quantitative ultrasound (QUS)
index (47). Men in the United States account for up to
30% of hip fracture diagnoses (48). Interestingly, male
hip fracture patients experience larger rates of morbidity
and mortality than their female counterparts (49).
Osteoporosis risk factors for men are specifically
glucocorticoid or anticonvulsant therapy, testosterone or
oestrogen deficiency, smoking, and alcohol
consumption (50). In particular, out of the 6.5 million
American men projected to suffer from symptomatic
androgen deficiency in 2025, 650,000 are expected to
suffer a fragility fracture as a consequence (51).
Furthermore, many men suffer from idiopathic
osteoporosis which can occur at any age (42).
Advanced age
Bone mineral deposition accelerates during childhood
and adolescence but trabecular bone loss begins early in
midlife and accelerates with increasing age (42).
Although menopause accounts for much of the
association between age and osteoporosis, bone ageing
occurs even before the menopause in many women
(52). The actual aetiology of age-related bone loss is
unknown, although it is understood to involve an
imbalance in bone remodelling. Possible explanations
include reduced osteoblast lifespan, increased
2008 McGill Journal of Medicine 54patients are false positives and may never have been at
increased risk of falling (4) A number of systematic
reviews have, however, shown that falls interventions
can reduce the rate of fracture in the elderly (67).
In addition to falls prevention, patients may use
mechanical protection such as hip protectors. Although
some trials have shown these to be ineffective, others
with longer follow-up times have implied a reduced hip
fracture risk (68). One systematic review of seven
randomised controlled trials (RCTs) found that hip
protectors reduce hip fracture risk by up to 66% (69).
Hip protectors are, however, affected by poor
compliance, with less than a third of patients using them
regularly (70). It is furthermore unclear whether hip
protectors are cost-effective (71). For this reason, their
use is limited.
CONCLUSION
Although a number of different factors can contribute
to osteoporosis, most of these reduce BMD by
interfering with the bone remodelling process.
Furthermore, many of the risk factors for osteoporosis
and hip fracture identified in this review are
preventable, particularly if challenged early in the
lifespan. For example, exercise and dietary intake are
important considerations at an early age, as skeletal
strength in old age is largely determined by mineral
deposition in childhood and adolescence (19).Agreater
understanding of the pathophysiology of osteoporosis is
likely to inform health promotion strategies aimed both
at primary and secondary prevention of this disease.
Furthermore, awareness of factors predisposing to falls
may help reduce the incidence of hip fracture among
those elderly persons already suffering from
osteoporosis.
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